MTSRNASDAQHealthcare · Biotechnology

Metsera, Inc.

$70.50-0.35%($-0.25)

TickerSpark Score

52/100

Mixed

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTSR research report →

52-Week Range81% of range

Low $12.30

Current $70.50

High $83.86

Companymetsera.com

Metsera, Inc. , a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity.

CEO: Christopher Whitten Bernard
IPO: 2025
Employees: 93
HQ: New York City, NY, US

Price Chart

+166.04% · this period

Valuation

Market Cap: $7.43B
P/E: -23.55
P/S: 0.00
P/B: 21.96
EV/EBITDA: -17.73
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -79.64%
ROIC: -71.17%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-209,127,000 · -343.01%
EPS: $-2.03 · -113.68%
Op Income: $-224,833,000
FCF YoY: -181.83%

Performance & Tape

52W High: $83.86
52W Low: $12.30
50D MA: $53.47
200D MA: $35.09
Beta: 1.70
Avg Volume: 3.50M

Get TickerSpark's AI analysis on MTSR

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Nov 13, 25	FMR LLC	10 percent owner, other: See Remark 1	other	2,230,450	$22.305
Nov 13, 25	ARCH Venture Partners XII, LLC	director, 10 percent owner:	sell	8,313,680	$83.137
Nov 13, 25	Marso Steven	officer: CHIEF MEDICAL OFFICER	other	17,000	$0
Nov 13, 25	Marso Steven	officer: CHIEF MEDICAL OFFICER	sell	17,000	$0.17
Nov 13, 25	Marso Steven	officer: CHIEF MEDICAL OFFICER	sell	21,279	$5.53K
Nov 13, 25	Marso Steven	officer: CHIEF MEDICAL OFFICER	sell	120,000	$3.51M
Nov 13, 25	BERNS PAUL L	director	other	4,031	$0
Nov 13, 25	BERNS PAUL L	director	sell	24,188	$707.50K
Nov 13, 25	BERNS PAUL L	director	sell	223,430	$1.83M
Nov 13, 25	BERNS PAUL L	director	sell	957,559	$9.576

Our MTSR Coverage

We haven't published any research on MTSR yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MTSR Report →